Biocardia, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Biocardia, Inc. (BCDA) on September 10, 2026. The filing reports an "Other Event" under Item 8.01 regarding an upcoming corporate presentation.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a notification of a corporate event and does not contain financial statements or performance data.
Material Changes
No material changes to financial position or operations are reported in this filing. The document solely announces a scheduled presentation by company leadership.
Guidance, Outlook, and Management Commentary
Peter Altman, Ph.D., President and Chief Executive Officer, is scheduled to present at the H.C. Wainwright 28th Annual Global Investment Conference. The event will take place at the Lotte New York Palace Hotel in New York City from September 14-16, 2026. A press release detailing this announcement is attached as Exhibit 99.1. The filing explicitly states that the information furnished is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings.
Investor Verification Checklist
- Verify the date and location of the H.C. Wainwright 28th Annual Global Investment Conference (September 14-16, 2026, New York City).
- Review the attached press release (Exhibit 99.1) for specific details on the presentation content.
- Confirm that no financial data or forward-looking guidance is included in this specific 8-K filing.
- Check subsequent filings for the actual transcript or summary of the CEO's presentation.